Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib
Zhao, Fei , Jia, Jie , Ma, Xianxiong , Jiang, Qi , Zhang, Ruizhi , Li, Chengguo , Wang, Tao , Liu, Weizhen , Hao, Yalan , Tao, Kaixiong , Zhang, Peng , Zeng, Xiangyu , Zhao, Fei , Jia, Jie , Ma, Xianxiong , Jiang, Qi , Zhang, Ruizhi , Li, Chengguo , Wang, Tao , Liu, Weizhen , Hao, Yalan , Tao, Kaixiong , Lou, Zhenkun , Zhang, Peng , Zeng, Xiangyu , Lou, Zhenkun

Mayo Clinic

Cancer Research | August 9, 2023 | Volume: 83 | Issue: 21 | Pages: 3624-3635

10.1158/0008-5472.can-23-0082 | PMID 37556508 Get It

Abstract Imatinib mesylate (IM) has revolutionized the treatment of gastrointestinal stromal tumor (GIST). However, most patients inevitably acquire IM resistance. Second- and third-line treatments exhibit modest clinical benefits with a median time to disease progression of 4 to 6 months, highlighting the urgency for novel therapeutic approaches. Here, we report that the expression of BCL6, a known oncogenic driver and transcriptional repressor, was significantly induced in GIST cells following IM treatment. Elevated BCL6 levels suppressed apoptosis and contributed to IM resistance. Mechanistically, BCL6 recruited SIRT1 to the TP53 promoter to modulate histone acetylation and transcriptionally repress TP53 expression. The reduction in p53 subsequently attenuated cell apoptosis and promoted tolerance of GIST cells to IM. Concordantly, treatment of GIST cells showing high BCL6 expression with a BCL6 inhibitor, BI-3802, conferred IM sensitivity. Furthermore, BI-3802 showed striking synergy with IM in IM-responsive and IM-resistant GIST cells in vitro and in vivo. Thus, these findings reveal a role for BCL6 in IM resistance and suggest that a combination of BCL6 inhibitors and IM could be a potentially effective treatment for GIST. Significance: BCL6 drives resistance to imatinib by inhibiting p53-mediated apoptosis and can be targeted in combination with imatinib to synergistically suppress tumor growth, providing a therapeutic strategy for treating gastrointestinal stromal tumor.
P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS AND SUBGROUP ANALYSIS FROM THE PHASE 1/2 BRUIN STUDY WITH >3 YEARS FOLLOW-UP FROM START OF ENROLLMENT
Eyre, Toby A. , Ujjani, Chaitra S. , Alencar, Alvaro J. , Lewis, David , Maddocks, Kami J. , Munir, Talha, Balbas, Minna, Tsai, Donald E. , Wang, Chunxiao , Wang, Michael , Shah, Nirav N. , Jurczak, Wojciech , Zinzani, Pier Luigi , Cheah, Chan Y. , Izutsu, Koji , Ma, Shuo , Flinn, Ian W. , Patel, Krish , Wang, Yucai , Zelenetz, Andrew D.

Mayo Clinic

HemaSphere | August 9, 2023 | Volume: 7 | Issue: S3 | Pages: e45636b5

10.1097/01.hs9.0000971244.45636.b5 Get It

An open natural language processing (NLP) framework for EHR-based clinical research: a case demonstration using the National COVID Cohort Collaborative (N3C)
Liu, Sijia , Wen, Andrew , Wang, Liwei , Fu, Sunyang , Miller, Robert , Williams, Andrew E. , Harris, Daniel R. , Liu, Mei , Abu-el-rub, Noor , Schutte, Dalton, Zhang, Rui , Osborne, John D. , He, Yongqun , Topaloĝlu, Ümit , Hong, Stephanie , Schaffter, Thomas , Fuentes, Rafael , Xu, Hua , He, Huan , Fu, Sunyang , Williams, Andrew , Harris, Daniel , Kavuluru, Ramakanth , Liu, Mei , Zhang, Rui , Rouhizadeh, Masoud , Osborne, John D , He, Yongqun , Topaloglu, Umit , Saltz, Joel H , Schaffter, Thomas , Pfaff, Emily , Chute, Christopher G , Haendel, Melissa , Szolovits, Peter , Xu, Hua , Liu, Hongfang , Liu, Sijia , Wen, Andrew , Abu-El-Rub, Noor , He, Huan , Saltz, Joel , Chute, Christopher G. , Duong, Timothy Q. , Haendel, Melissa , Liu, Hongfang

Mayo Clinic

Journal of the American Medical Informatics Association | August 8, 2023 | Volume: 30 | Issue: 12 | Pages: 2036-2040

10.1093/jamia/ocad134 | PMID 37555837 Get It

Abstract Despite recent methodology advancements in clinical natural language processing (NLP), the adoption of clinical NLP models within the translational research community remains hindered by process heterogeneity and human factor variations. Concurrently, these factors also dramatically increase the difficulty in developing NLP models in multi-site settings, which is necessary for algorithm robustness and generalizability. Here, we reported on our experience developing an NLP solution for Coronavirus Disease 2019 (COVID-19) signs and symptom extraction in an open NLP framework from a subset of sites participating in the National COVID Cohort (N3C). We then empirically highlight the benefits of multi-site data for both symbolic and statistical methods, as well as highlight the need for federated annotation and evaluation to resolve several pitfalls encountered in the course of these efforts.
P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY
Cohen, Jonathon B. , Eyre, Toby A. , Woyach, Jennifer A. , Seymour, John F. , Wang, Michael , Loubert, Angély , Hess, Lisa M. , Abada, Paolo, Mato, Anthony R. , Roeker, Lindsey E. , Cheah, Chan Y. , Patel, Krish , Wang, Yucai , Payakachat, Nalin , Ghia, Paolo

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e34270c5

10.1097/01.hs9.0000971344.34270.c5 Get It

S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HIGH-RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY
Patriarca, Andrea, Rivera, Candido E., Granacher, Nikki, Palmer, Jeanne , Rampal, Raajit K. , Eliane, Jean-Pierre, Chang, Tzuu-Wang, Klein, Sandra, Colak, Gozde , Harrison, Claire , Passamonti, Francesco , Patriarca, Andrea , Knapper, Steven , Scandura, Joseph Michael , Devos, Timothy , Mead, Adam J. , Oh, Stephen T. , Teichmann, Lino Lars , Li, Qing

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e9927843

10.1097/01.hs9.0000967584.99278.43 Get It

Age-associated changes in lineage composition of the enteric nervous system regulate gut health and disease
Kulkarni, Subhash , Saha, Monalee , Slosberg, Jared , Nagaraj, Sushma , Becker, Laren , Zhang, Chengxiu , Bukowski, Alicia, Wang, Zhuolun, Liu, Guosheng , Leser, Jenna , Bakhshi, Shriya, Vincent, Elizabeth , Goff, Loyal A. , Pasricha, Pankaj J. , Singh, Alpana , Nagaraj, Sushma , Leser, Jenna M , Anderson, Matthew J , Lewandoski, Mark , Goff, Loyal A , Pasricha, Pankaj Jay , Kulkarni, Subhash , Singh, Alpana , Kumar, Mithra R.

Mayo Clinic

eLife | August 8, 2023 | Volume: 12 | Issue: No issue available | Pages: No page available

10.7554/elife.88051 | PMID 38108810 Get It

The enteric nervous system (ENS), a collection of neural cells contained in the wall of the gut, is of fundamental importance to gastrointestinal and systemic health. According to the prevailing paradigm, the ENS arises from progenitor cells migrating from the neural crest and remains largely unchanged thereafter. Here, we show that the lineage composition of maturing ENS changes with time, with a decline in the canonical lineage of neural-crest derived neurons and their replacement by a newly identified lineage of mesoderm-derived neurons. Single cell transcriptomics and immunochemical approaches establish a distinct expression profile of mesoderm-derived neurons. The dynamic balance between the proportions of neurons from these two different lineages in the post-natal gut is dependent on the availability of their respective trophic signals, GDNF-RET and HGF-MET. With increasing age, the mesoderm-derived neurons become the dominant form of neurons in the ENS, a change associated with significant functional effects on intestinal motility which can be reversed by GDNF supplementation. Transcriptomic analyses of human gut tissues show reduced GDNF-RET signaling in patients with intestinal dysmotility which is associated with reduction in neural crest-derived neuronal markers and concomitant increase in transcriptional patterns specific to mesoderm-derived neurons. Normal intestinal function in the adult gastrointestinal tract therefore appears to require an optimal balance between these two distinct lineages within the ENS.
Age-associated changes in lineage composition of the enteric nervous system regulate gut health and disease
Saha, Monalee , Slosberg, Jared , Nagaraj, Sushma , Becker, Laren , Zhang, Chengxiu , Bukowski, Alicia, Wang, Zhuolun, Liu, Guosheng , Leser, Jenna , Bakhshi, Shriya, Vincent, Elizabeth , Pasricha, Pankaj J. , Kulkarni, Subhash , Singh, Alpana , Kumar, Mithra R. , Anderson, Matthew J , Lewandoski, Mark , Goff, Loyal A.

Mayo Clinic

No container title available | August 8, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.88051.1 Get It

Abstract The enteric nervous system (ENS), a collection of neural cells contained in the wall of the gut, is of fundamental importance to gastrointestinal and systemic health. According to the prevailing paradigm, the ENS arises from progenitor cells migrating from the neural crest and remains largely unchanged thereafter. Here, we show that the lineage composition of maturing ENS changes with time, with a decline in the canonical lineage of neural-crest derived neurons and their replacement by a newly identified lineage of mesoderm-derived neurons. Single cell transcriptomics and immunochemical approaches establish a distinct expression profile of mesoderm-derived neurons. The dynamic balance between the proportions of neurons from these two different lineages in the post-natal gut is dependent on the availability of their respective trophic signals, GDNF-RET and HGF-MET. With increasing age, the mesoderm-derived neurons become the dominant form of neurons in the ENS, a change associated with significant functional effects on intestinal motility which can be reversed by GDNF supplementation. Transcriptomic analyses of human gut tissues show reduced GDNF-RET signaling in patients with intestinal dysmotility which is associated with reduction in neural crest-derived neuronal markers and concomitant increase in transcriptional patterns specific to mesoderm-derived neurons. Normal intestinal function in the adult gastrointestinal tract therefore appears to require an optimal balance between these two distinct lineages within the ENS.
Cobind: quantitative analysis of the genomic overlaps
Ma, Tao , Guo, Lingyun, Yan, Huihuang , Wang, Liguo , Wang, Liguo , Ma, Tao

Mayo Clinic

Bioinformatics Advances | August 7, 2023 | Volume: 3 | Issue: 1 | Pages: No page available

10.1093/bioadv/vbad104 | PMID 37600846 Get It

Abstract Motivation Analyzing the overlap between two sets of genomic intervals is a frequent task in the field of bioinformatics. Typically, this is accomplished by counting the number (or proportion) of overlapped regions, which applies an arbitrary threshold to determine if two genomic intervals are overlapped. By making binary calls but disregarding the magnitude of the overlap, such an approach often leads to biased, non-reproducible, and incomparable results. Results We developed the cobind package, which incorporates six statistical measures: the Jaccard coefficient, Sørensen–Dice coefficient, Szymkiewicz–Simpson coefficient, collocation coefficient, pointwise mutual information (PMI), and normalized PMI. These measures allow for a quantitative assessment of the collocation strength between two sets of genomic intervals. To demonstrate the effectiveness of these methods, we applied them to analyze CTCF’s binding sites identified from ChIP-seq, cancer-specific open-chromatin regions (OCRs) identified from ATAC-seq of 17 cancer types, and oligodendrocytes-specific OCRs identified from scATAC-seq. Our results indicated that these new approaches effectively re-discover CTCF’s cofactors, as well as cancer-specific and oligodendrocytes-specific master regulators implicated in disease and cell type development. Availability and implementation The cobind package is implemented in Python and freely available at https://cobind.readthedocs.io/en/latest/.